Elgouhary, S.M.; Bayomy, N.R.; Elfarash, M.K.; Aboali, S.Z.; Barakat, S.A.; Elnaggar, M.A.; Gaber, N.K.
Re-Evaluating the Treatment Plan for Diabetic Macular Edema Based on Early Identification of Response and Possible Biochemical Predictors of Non-Response After the First Intravitreal Ranibizumab Injection. Biomedicines 2025, 13, 2438.
https://doi.org/10.3390/biomedicines13102438
AMA Style
Elgouhary SM, Bayomy NR, Elfarash MK, Aboali SZ, Barakat SA, Elnaggar MA, Gaber NK.
Re-Evaluating the Treatment Plan for Diabetic Macular Edema Based on Early Identification of Response and Possible Biochemical Predictors of Non-Response After the First Intravitreal Ranibizumab Injection. Biomedicines. 2025; 13(10):2438.
https://doi.org/10.3390/biomedicines13102438
Chicago/Turabian Style
Elgouhary, Sameh Mohamed, Noha Rabie Bayomy, Mohamed Khaled Elfarash, Sara Zakaria Aboali, Sara Abdelmageed Barakat, Mona Abdelhamid Elnaggar, and Noha Khirat Gaber.
2025. "Re-Evaluating the Treatment Plan for Diabetic Macular Edema Based on Early Identification of Response and Possible Biochemical Predictors of Non-Response After the First Intravitreal Ranibizumab Injection" Biomedicines 13, no. 10: 2438.
https://doi.org/10.3390/biomedicines13102438
APA Style
Elgouhary, S. M., Bayomy, N. R., Elfarash, M. K., Aboali, S. Z., Barakat, S. A., Elnaggar, M. A., & Gaber, N. K.
(2025). Re-Evaluating the Treatment Plan for Diabetic Macular Edema Based on Early Identification of Response and Possible Biochemical Predictors of Non-Response After the First Intravitreal Ranibizumab Injection. Biomedicines, 13(10), 2438.
https://doi.org/10.3390/biomedicines13102438
